Skip to main content
CDC Website

Community Based Organizations

Mpox Virus

This fact sheet discusses how mpox is a rare but potentially serious disease that is caused by the mpox virus. The mpox virus is from the same family of viruses as the smallpox virus. The symptoms of mpox are similar to smallpox symptoms, but are less severe. It is also less transmissible than smallpox, and rarely fatal. The mpox virus can spread from infected humans, animals, and materials contaminated with the virus. The mpox virus is characterized by a new unexplained rash and skin lesions.

Research Activities to Advance Mpox Treatment

One of four pre-recorded video presentations on the current landscape of U.S. government-supported mpox research. The highlighted research efforts include Phase III clinical trials of tecovirimat (TPOXX) to treat mpox.

Mpox Vaccine: U.S. Government Research Update

A video summary of current scientific studies conducted by U.S. government agencies on mpox vaccine effectiveness, safety, equity, and development.

Injection Drug Use (IDU) Infographic

This infographic discusses how in 2018, injection drug use (IDU) was highest among men (21%),

Hepatitis Can’t Wait: Using the Global Health Sector Strategy and its 2025 Targets to Drive Change

This video discusses an overview of the new GHSS, the five strategic directions, and the 2025 and 2030 targets. 

The progress countries have made to these goals and what needs to be done to achieve them.   

How community-based organizations and activists can use the GHSS and its targets for advocacy and to hold countries and health systems accountable to their commitments.  

Good practice examples of using the previous GHSS for advocacy and how countries have used GHSS in the planning and implementation of their national programmes.  

Pulmonary Outcomes and Sequelae after Treatment-TB (POST-TB) (R01 Clinical Trial Optional)

The purpose of this Funding Opportunity Announcement (FOA) is to support applications for epidemiological and observational research projects on the long-term cardiopulmonary sequelae following treatment for tuberculosis (TB). Investigators should propose additional testing and data collection in existing cohorts of adult and/or pediatric TB participants to better characterize and understand adverse outcomes and morbidity associated with TB disease post treatment in individuals with and without HIV infection.

NIDA Avant-Garde Program for HIV and Substance Use Disorder Research (DP1 Clinical Trial Optional)

The NIDA Avant-Garde Award Program for HIV/AIDS Research supports individual scientists of exceptional creativity who propose high-impact research that will open new areas of HIV/AIDS research relevant to drug abuse and/or lead to new avenues for prevention and treatment of HIV/AIDS among drug abusers. The term avant-garde is used to describe highly innovative approaches that have the potential to be transformative.